Thymoquinone Anticancer Effects Through the Upregulation of NRF2 and the Downregulation of PD‐L1 in MDA‐MB‐231 Triple‐Negative Breast Cancer Cells

G Adinew, SS Messeha, R Badisa, E Taka… - The FASEB …, 2022 - Wiley Online Library
Triple‐negative breast cancer (TNBC) is an aggressive subtype of breast cancer with a
metastatic nature. TNBC lacks the expression of the progesterone receptor, estrogen …
被引用次数：13 相关文章

Thymoquinone Anticancer Effects Through the Upregulation of NRF2 and the Downregulation of PD-L1 in MDA-MB-231 Triple-Negative Breast Cancer Cells

G Adinew, SS Messeha, R Badisa… - … publication of the …, 2022 - pubmed.ncbi.nlm.nih.gov
Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer with a
metastatic nature. TNBC lacks the expression of the progesterone receptor, estrogen …

Thymoquinone Anticancer Effects Through the Upregulation of NRF2 and the Downregulation of PD-L1 in MDA-MB-231 Triple-Negative Breast Cancer Cells.

G Adinew, SS Messeha, R Badisa, E Taka… - … : Official Publication of …, 2022 - europepmc.org
Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer with a
metastatic nature. TNBC lacks the expression of the progesterone receptor, estrogen …